21-46151751-C-T
Variant names:
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 2P and 10B. PM2BP4_StrongBP6_ModerateBS1
The NM_206965.2(FTCD):c.457-14G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000278 in 1,612,426 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.00081 ( 0 hom., cov: 34)
Exomes 𝑓: 0.00022 ( 0 hom. )
Consequence
FTCD
NM_206965.2 intron
NM_206965.2 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -2.02
Genes affected
FTCD (HGNC:3974): (formimidoyltransferase cyclodeaminase) The protein encoded by this gene is a bifunctional enzyme that channels 1-carbon units from formiminoglutamate, a metabolite of the histidine degradation pathway, to the folate pool. Mutations in this gene are associated with glutamate formiminotransferase deficiency. Alternatively spliced transcript variants have been found for this gene.[provided by RefSeq, Dec 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -8 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.87).
BP6
Variant 21-46151751-C-T is Benign according to our data. Variant chr21-46151751-C-T is described in ClinVar as [Benign]. Clinvar id is 1600618.Status of the report is criteria_provided_single_submitter, 1 stars.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.000807 (123/152364) while in subpopulation AFR AF= 0.00274 (114/41586). AF 95% confidence interval is 0.00233. There are 0 homozygotes in gnomad4. There are 59 alleles in male gnomad4 subpopulation. Median coverage is 34. This position pass quality control queck.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FTCD | NM_206965.2 | c.457-14G>A | intron_variant | Intron 4 of 13 | ENST00000397746.8 | NP_996848.1 | ||
FTCD | NM_001320412.2 | c.457-14G>A | intron_variant | Intron 4 of 14 | NP_001307341.1 | |||
FTCD | NM_006657.3 | c.457-14G>A | intron_variant | Intron 4 of 14 | NP_006648.1 | |||
FTCD-AS1 | NR_170989.1 | n.138C>T | non_coding_transcript_exon_variant | Exon 1 of 2 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000808 AC: 123AN: 152246Hom.: 0 Cov.: 34
GnomAD3 genomes
AF:
AC:
123
AN:
152246
Hom.:
Cov.:
34
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000302 AC: 75AN: 247946Hom.: 0 AF XY: 0.000297 AC XY: 40AN XY: 134844
GnomAD3 exomes
AF:
AC:
75
AN:
247946
Hom.:
AF XY:
AC XY:
40
AN XY:
134844
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000223 AC: 325AN: 1460062Hom.: 0 Cov.: 32 AF XY: 0.000204 AC XY: 148AN XY: 726310
GnomAD4 exome
AF:
AC:
325
AN:
1460062
Hom.:
Cov.:
32
AF XY:
AC XY:
148
AN XY:
726310
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000807 AC: 123AN: 152364Hom.: 0 Cov.: 34 AF XY: 0.000792 AC XY: 59AN XY: 74504
GnomAD4 genome
AF:
AC:
123
AN:
152364
Hom.:
Cov.:
34
AF XY:
AC XY:
59
AN XY:
74504
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
Asia WGS
AF:
AC:
2
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Glutamate formiminotransferase deficiency Benign:1
May 31, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at